Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Expert insights: Adapting treatment during the COVID-19 pandemic
Date
14 Sep 2020Session
Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continuePresenters
Pippa CorrieAuthors
J. Larkin1, P.A. Ascierto2, P. Corrie3Author affiliations
- 1 Medicine Department, The Royal Marsden Hospital - NHS Foundation Trust, SW3 6JJ - London/GB
- 2 Melanoma, Cancer Immunotherapy & Developmental Therapeutics, Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, 80131 - Napoli/IT
- 3 Department Of Oncology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, CB2 0QQ - Cambridge/GB
Resources
Resources from the same session
Welcome and Introduction
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Emerging long-term survival data and implications for clinical practice
Presenter: Pippa Corrie
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Studying survival: An evidence-based approach to improving outcomes
Presenter: Paolo Ascierto
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Summary and close
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Live Q&A - 23 September 2020 - 10:00-10:30
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast